Keymed Biosciences Inc. (2162.HK)

HKD 33.0

(-1.93%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Total Assets 3.88 Billion 3.93 Billion 3.93 Billion 529.94 Million 658.57 Million
Total Current Assets 2.93 Billion 3.3 Billion 3.58 Billion 380.91 Million 518.4 Million
Cash And Short Term Investments 2.71 Billion 3.17 Billion 3.52 Billion 354.08 Million 498.94 Million
Cash and Cash Equivalents 851.02 Million 604.07 Million 1.52 Billion 199.4 Million 432.6 Million
Short Term Investments 1.86 Billion 2.57 Billion 2 Billion 154.67 Million 66.34 Million
Net Receivables 27.09 Million 480 Thousand 10.55 Million -10.39 Million -66.34 Million
Inventory 56.35 Million 44.49 Million 16.39 Million 6.84 Million 3.3 Million
Other Current Assets 311.27 Million 315.02 Million 77.79 Million 25.89 Million 82.43 Million
Total Non-Current Assets 943.39 Million 622.34 Million 352.5 Million 149.02 Million 140.17 Million
Net PPE 910.94 Million 596.46 Million 306.48 Million 126.14 Million 128.94 Million
Good Will And Intangible Assets 5.23 Million 1.49 Million 1.1 Million 109 Thousand 38 Thousand
Good Will - - - - -
Intangible Assets 5.23 Million 1.49 Million 1.1 Million 109 Thousand 38 Thousand
Long-Term Investments 21.63 Million -2.55 Billion -1.98 Billion - -
Tax Assets -21.32 Million 2.55 Billion - - -
Other Non Current Assets 26.91 Million 24.38 Million 2.02 Billion 22.77 Million 11.19 Million
Other Assets - - - - -
Total Liabilities 896.1 Million 593.09 Million 289.07 Million 1.62 Billion 934.53 Million
Total Current Liabilities 314.18 Million 379.69 Million 112.07 Million 80.24 Million 71.59 Million
Account Payables 29.48 Million 14.91 Million 2.78 Million 3.41 Million 3.47 Million
Tax Payables 1.82 Million 1.02 Million 935 Thousand 161 Thousand 107 Thousand
Short Term Debt 65.25 Million 72.24 Million 12.27 Million 46.55 Million 52.17 Million
Deferred Revenue -19.42 Million - - - -
Other Current Liabilities 238.86 Million 292.54 Million 97.01 Million 30.27 Million 15.93 Million
Total Non Current Liabilities 581.92 Million 213.39 Million 176.99 Million 1.54 Billion 862.94 Million
Long-Term Debt 353.45 Million 49.72 Million 26.98 Million 20.31 Million 24.27 Million
Deferred Revenue Non Current 228.19 Million 163.67 Million 8.71 Million 6.78 Million 1.58 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities - -28.8 Million 141.29 Million 1.51 Billion 837.08 Million
Other Liabilities - - - - -
Total Equity 2.98 Billion 3.33 Billion 3.64 Billion -1.09 Billion -275.95 Million
Stock Holders Equity 2.98 Billion 3.34 Billion 3.65 Billion -1.09 Billion -275.95 Million
Common Stock 169 Thousand 170 Thousand 171 Thousand 45 Thousand 45 Thousand
Retained Earnings -5.64 Billion -5.29 Billion 3.65 Billion -1.09 Billion -276 Million
Accumulated other comprehensive income 2.98 Billion 144.97 Million 116.82 Million - -
Common Stock Equity 2.98 Billion 3.34 Billion 3.65 Billion -1.09 Billion -275.95 Million
Capital Lease Obligation 41.05 Million 32 Million 38.7 Million 24.49 Million 28.7 Million
Total Investments 21.63 Million 20.57 Million 20.28 Million 154.67 Million 66.34 Million
Total Debt 418.7 Million 121.96 Million 39.26 Million 66.86 Million 76.44 Million
Net Debt -432.32 Million -482.1 Million -1.48 Billion -132.54 Million -356.16 Million

Balance Sheet Charts